Michael H. Mulroy

Insider Reports History

Entity
Individual
Location
1300 N. Kellogg Drive, Suite D, Anaheim, CA
Signature
/s/ Daniel Collins, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael H. Mulroy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lineage Cell Therapeutics, Inc. Director Common Shares 299K $169K $0.57 Nov 22, 2024 Direct
Lineage Cell Therapeutics, Inc. Director Stock Option (Right to Buy) 75K Jul 1, 2024 Direct

Insider Reports Filed by Michael H. Mulroy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LCTX Lineage Cell Therapeutics, Inc. Nov 22, 2024 1 $22.6K 4 Nov 25, 2024 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2024 1 $0 4 Jul 3, 2024 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2023 1 $0 4 Jul 3, 2023 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Director
LCTX Lineage Cell Therapeutics, Inc. Mar 24, 2022 1 $9.8K 4 Mar 25, 2022 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2021 1 $0 4 Jul 1, 2021 Director
LCTX Lineage Cell Therapeutics, Inc. Jun 18, 2021 2 $54.4K 4 Jun 21, 2021 Director